share

Quinoxaline, 1-Acetyl-1,2,3,4-Tetrahydro-4-Methyl- (9Ci) CAS NO 669695-07-2


Unit Price:

CAS No.:669695-07-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Quinoxaline, 1-Acetyl-1,2,3,4-Tetrahydro-4-Methyl- (9Ci) is a specialized heterocyclic organic compound belonging to the quinoxaline family, serving as a valuable synthetic intermediate. Its core value proposition lies in its functionalized structure, which makes it a versatile building block for constructing more complex molecules in advanced chemical synthesis. This compound is primarily needed by research and development chemists in the pharmaceutical and agrochemical industries, where it is utilized in the discovery and development of new active ingredients.

Application

  • Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or possessing antimicrobial properties.
  • Agrochemical Research: Used in the development of new herbicides, fungicides, and insecticides, leveraging the bioactive quinoxaline scaffold.
  • Organic Synthesis Building Block: Employed in academic and industrial R&D for constructing complex heterocyclic systems and fine chemicals due to its acetyl and tetrahydroquinoxaline moieties.
  • Material Science Research: Investigated as a potential monomer or precursor for functional polymers and advanced organic materials with specific electronic or optical properties.

Basic Information

Product Name Quinoxaline, 1-Acetyl-1,2,3,4-Tetrahydro-4-Methyl- (9Ci)
CAS No. 669695-07-2
Molecular Formula C11H14N2O
Molecular Weight 190.24 g/mol
Synonyms 1-Acetyl-4-methyl-1,2,3,4-tetrahydroquinoxaline; 4-Methyl-1,2,3,4-tetrahydro-1-quinoxalinecarboxaldehyde, 1-acetyl derivative; 1-(4-Methyl-3,4-dihydro-2H-quinoxalin-1-yl)ethanone; 1-Acetyl-4-methyl-1,2,3,4-tetrahydroquinoxaline (9CI); Tetrahydroquinoxaline derivative; Quinoxaline carboxamide precursor
EINECS Contact for details

Quality Control

Our Quinoxaline, 1-Acetyl-1,2,3,4-Tetrahydro-4-Methyl- (9Ci) is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing specifications such as assay (HPLC), identity (IR, NMR), and impurity profiles are available upon request to support your quality assurance and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at room temperature (15-25°C). Keep away from incompatible materials. Due to its light-sensitive nature, containers should be amber-colored or stored in light-resistant secondary packaging.

Specification

Item Specification
Appearance White to off-white powder or crystalline solid
Identification (IR) Conforms to structure
Assay (HPLC) ≥ 97.0%
Related Substances (HPLC) Total impurities ≤ 3.0%
Residual Solvents (GC) Complies with ICH guidelines
Loss on Drying ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.